Scholar Rock updates apitegromab regulatory status in U.S., Europe, Japan
Go back to Scholar Rock updates apitegromab regulatory status in U.S., Europe, Japan| (NASDAQ: SRRK) | Delayed: 55.39 +0.77 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.62 | 52 Week High | $ | |||
| Open | $54.01 | 52 Week Low | $ | |||
| Day High | $56.71 | P/E | N/A | |||
| Day Low | $53.86 | EPS | $ | |||
| Volume | 755,396 | |||||

